Inventor · disambiguated record
Nikolay Filippovich Savchuk
Also filed as: SAVCHUK NIKOLAY · SAVCHUK NIKOLAY FILIPPOVICH
17 granted patents·39 pending applications·63 citations·filing 2007–2024
91Inventor score
Files withIVACHTCHENKO ALEXANDRE VASILIEVICH12IVASHCHENKO ANDREY ALEXANDROVICH12EIL THERAPEUTICS INC5ALLA CHEM LLC3BALA THERAPEUTICS INC2
Top patents by PatentIndex Score
56 records- 0191US8541437B2Substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles, methods for the production and use thereofIVASHCHENKO ANDREY ALEXANDROVICH·Filed 2008·Granted Sep 24, 2013·34 cites·11 claims
- 0284US11648300B1Pharmaceutical combination therapy and prevention with aprotinin + nirmatrelvir of SARS-CoV-2 and/or disease associated with this infection, including COVID-19ASAVI LLC·Filed 2022·Granted May 16, 2023·2 cites·13 claims
- 0381US8486945B2Heterocyclic inhibitors of an Hh-signal cascade, medicinal compositions based thereon and methods for treating diseases caused by the aberrant activity of an Hh-signal systemIVASHCHENKO ANDREY·Filed 2008·Granted Jul 16, 2013·7 cites·5 claims
- 0479US10266558B2Macroheterocyclic nucleoside derivatives and their analogues, production and use thereofIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2016·Granted Apr 23, 2019·2 cites·4 claims
- 0577US8552017B22-amino-3-sulphonyl-tetrahydro-pyrazolo[1,5-A]pyrido-pyrimidine antagonists of serotonin 5-HT6 receptors, methods for the production and use thereofIVASHCHENKO ANDREY ALEXANDROVICH·Filed 2009·Granted Oct 8, 2013·3 cites·12 claims
- 0677US8471009B2(EN) 2-alkylamino-3-arylsulfonyl-cycloalcano [e OR d] pyrazolo [1,5-A]pyrimidines / antagonists of serotonin 5-HT6 receptors, methods for the production and the use thereofIVASHCHENKO ANDREY ALEXANDROVICH·Filed 2009·Granted Jun 25, 2013·3 cites·10 claims
- 0775US8569318B2Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-HT6 receptors, methods for the production and use thereofIVASHCHENKO ANDREY ALEXANDROVICH·Filed 2009·Granted Oct 29, 2013·2 cites·13 claims
- 0875US8329689B2Substituted indoles and a method for the production and use thereofIVASHCHENKO ANDREY ALEXANDROVICH·Filed 2007·Granted Dec 11, 2012·3 cites·20 claims
- 0973US8309559B2(EN) substituted 2-amino-3-sulfonyl-pyrazolo[1,5-A] pyrimidines/antagonists of serotonin 5-HT6 receptors, methods for the production and the use thereofSAVCHUK NIKOLAY FILIPPOVICH·Filed 2009·Granted Nov 13, 2012·3 cites·5 claims
- 1071US8629154B2Substituted cycloalcano[e and d] pyrazolo [1,5-a]pyrimidines/antagonists of serotonin 5-HT6 receptors and methods for production and the use thereofIVASHCHENKO ANDREY ALEXANDROVICH·Filed 2009·Granted Jan 14, 2014·1 cites·9 claims
- 1170US8552005B2(EN) 3-sulfonyl-pyrazolo[1,5-a] pyrimidines / antagonists of serotonin 5-HT6 receptors, methods for the production and the use thereofIVASHCHENKO ANDREY ALEXANDROVICH·Filed 2009·Granted Oct 8, 2013·1 cites·10 claims
- 1269US2023346899A1PHARMACEUTICAL COMBINATION THERAPY AND PREVENTION WITH APROTININ + NIRMATRELVIR OF SARS-CoV-2 AND/OR DISEASE ASSOCIATED WITH THIS INFECTION, INCLUDING COVID-19IVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2023·Application pending·0 cites
- 1368US8618114B2Substituted 3-arylsulfonyl-pyrazolo[1,5-A]pyrimidines, serotonin 5-HT6 receptor antagonists and methods for the production and use thereofIVASHCHENKO ANDREY ALEXANDROVICH·Filed 2009·Granted Dec 31, 2013·1 cites·13 claims
- 1468US2025185648A1Method, device, and cardioplegic solution for the preservation of a donor heartIVACHTCHENKO ALEXANDRE·Filed 2023·Application pending·0 cites
- 1564US2025376464A1Compounds for treatment a coronavirus infectionTRAWSFYNYDD THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1662US2025032598A1Compounds, Pharmaceuticals, Formulations, and Methods for Treating and Preventing RNA Virus Infections and Associated DiseasesIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2023·Application pending·0 cites
- 1760US2025163061A1Inhibitors of menin-mll interactionBALA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1858US8829009B2Substituted 2-amino-3-(sulfonyl)pyrazolo[1,5-a]pyrimidines - serotonin 5-HT6 receptor antagonists, method for use thereofIVASHTCHENKO ALEXANDER VASILLEVICH·Filed 2012·Granted Sep 9, 2014·1 cites·3 claims
- 1958US2011039825A1Ligands of alpha-adrenoceptors, dopamine, histamine, imidazoline and serotonin receptors and their useALLA CHEM LLC·Filed 2008·Application pending·0 cites
- 2057US2023310480A1PHARMACEUTICAL COMBINATION THERAPY AND PREVENTION WITH APROTININ + MOLNUPIRAVIR OF SARS-CoV-2 AND/OR DISEASE ASSOCIATED WITH THIS INFECTION, INCLUDI COVID-19IVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2022·Application pending·0 cites
- 2157US2023310544A1ANTI-RNA VIRAL PHARMACEUTICAL COMBINATION THERAPY WITH APROTININ + anti-RNA DRUGIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2022·Application pending·0 cites
- 2257US2025090055A1Method and device for determining ischemic injuries of mammalian organs and tissuesIVACHTCHENKO ALEXANDRE·Filed 2023·Application pending·0 cites
- 2357US2023310467A1PHARMACEUTICAL COMBINATION THERAPY AND PREVENTION WITH APROTININ + REMDESIVIR OF SARS-CoV-2 AND/OR DISEASE ASSOCIATED WITH THIS INFECTION, INCLUDI COVID-19IVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2022·Application pending·0 cites
- 2455US2024270699A1Compounds having n-arylpyrimidin-2-amine derivatives as therapeutic agentsLOMOND THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2554US2024262801A1Compounds having 5-(2-fluoro-6-hydroxyphenyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxide as inhibitors of protein kinase phosphatase enzymesNESS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2654US2025313554A1Ptpn2 inhibitorsNESS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2754US2025282795A1EGFR Inhibitors in cancer treatmentCELYN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2854US2025270212A1Chimeric compounds useful in treating diseasesPADARN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2954US2025011319A1SUBSTITUTED 1H-PYRAZOLO [4,3-c] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOFLOMOND THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3054US2025066358A1Inhibitors of Menin-MLL InteractionBALA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3153US2025248998A1LRRK2 InhibitorsBRENIG THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3253US2011245231A1Active substance and pharmaceutical composition for treating alcohol dependence, and a method for obtaining and the use of said active substanceALLA CHEM LLC·Filed 2009·Application pending·0 cites
- 3353US2025163066A1PROTACs of MALT1TEGID THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3452US8481587B2Substituted 2-(5-hydroxy-2-methyl-1H-indole-3-yl)acetic acids and ethers thereof and the use of same to treat viral diseasesIVASHCHENKO ANDREY ALEXANDROVICH·Filed 2009·Granted Jul 9, 2013·0 cites·19 claims
- 3551US9655886B2Substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles, methods for use thereofIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2015·Granted May 23, 2017·0 cites·8 claims
- 3651US2023372458A1Antiviral agent for combined therapy of covid-19 (sars-cov-2)IVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2020·Application pending·0 cites
- 3751US2013217703A1Sustituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for use thereofALLA CHEM LLC·Filed 2013·Application pending·0 cites
- 3850US2024043424A1Compounds having ((3-nitrophenyl)sulfonyl)acetamide as bcl-2 inhibitorsEIL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3949US2023020329A1Annelated 9-hydroxy-1,8-dioxo-1,3,4,8-tetrahydro-2H-pyrido[1,2-a]pyrazine-7-carboxamides as HIV integrase inhibitors, methods of preparation and application thereofIvachtchenko Alexandrovna Alena·Filed 2020·Application pending·0 cites
- 4049US2023158021A1SARS-CoV-2 Antiviral Pharmaceutical Composition and Application ThereofLLC CROMIS LLC CROMIS·Filed 2021·Application pending·0 cites
- 4149US2025115577A1BCL-2 InhibitorsEIL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4249US2024415944A1Aqueous aprotinin-containing antiviral pharmaceutical compositionIVASHCHENKO ANDREY ALEXANDROVICH·Filed 2021·Application pending·0 cites
- 4349US2023357238A1Compounds having ((3-nitrophenyl)sulfonyl)acetamide as bcl-2 inhibitorsEIL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4448US2022096421A1Active Ingredient, Pharmaceutical Composition, and Medicinal Product for HIV and AIDS TherapyIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2020·Application pending·0 cites
- 4548US2023128176A1Anti-RNA virus, including anti-SARS-CoV-2 virus, pharmaceutical composition AvifavirLLC CROMIS LLC CROMIS·Filed 2020·Application pending·0 cites
- 4647US2023181704A1Anti-sars-cov-2 virus agent antiprovirIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2020·Application pending·0 cites
- 4746US2011046368A1Ligands of 5-ht6 receptors, a pharmaceutical composition, method for the production and use thereofIVASHCHENKO ANDREY ALEXANDROVICH·Filed 2007·Application pending·0 cites
- 4845US11697650B2Compounds having tetrahydroindolizine-1-carboxamide as BCL-2 inhibitorsEIL THERAPEUTICS INC·Filed 2022·Granted Jul 11, 2023·0 cites·61 claims
- 4945US2023158020A1Method for treating RNA viral infections, including COVID-19 (SARS-CoV-2)IVASCHENKO ALEXANDRE VASILIEVICH·Filed 2020·Application pending·0 cites
- 5045US2020129533A1Pharmaceutical nanosuspension for the therapy of hiv infectionIvachtchenko Alena Alexandrovna·Filed 2018·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Nikolay Filippovich Savchuk files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →